Status:
COMPLETED
Improving Asthma Outcomes in an Urban Pediatric Population
Lead Sponsor:
Stephen J. Teach, MD, MPH
Collaborating Sponsors:
American Academy of Allergy, Asthma, and Immunology
Robert Wood Johnson Foundation
Conditions:
Asthma
Eligibility:
All Genders
12-17 years
Phase:
NA
Brief Summary
Little is known about how ED-based programs can help to reduce pediatric ED visits for asthma. The current study evaluated a novel intervention in which the ED itself became the site of highly individ...
Detailed Description
Prospective, randomized clinical trial of a single visit to a specialized emergency department-based asthma follow-up clinic occurring 2-15 days after emergency department care for an acute exacerbati...
Eligibility Criteria
Inclusion
- age between 12 months and 17 years, inclusive;
- prior physician-diagnosed asthma;
- ≥1 other unscheduled visit for asthma in the previous 6 months and/or ≥1 hospitalization for asthma in the prior 12 months;
- a parent/guardian available for interview;
- residence in Washington, DC or a contiguous Maryland county; and
- requirement for ≥3 doses of nebulized albuterol in the ED at the time of enrollment.
Exclusion
- significant medical co-morbidities affecting the cardiorespiratory system;
- a visit to an allergist or a pulmonologist in the prior 6 months;
- ≥2 of the following: a current written asthma medical action plan, current use of \>1 controller medication, or a scheduled visit for asthma care with their PCP in the prior two weeks;
- enrollment in another asthma research study;
- unavailability for telephone follow-up; or
- primary language other than English or Spanish.
Key Trial Info
Start Date :
April 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2005
Estimated Enrollment :
488 Patients enrolled
Trial Details
Trial ID
NCT00140439
Start Date
April 1 2002
End Date
June 1 2005
Last Update
August 25 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's National Medical Center
Washington D.C., District of Columbia, United States, 20010